SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jul 8, 2026

PTCT

PTC THERAPEUTICS, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago
Insider cluster: 2 insiders, $776K total
Actionable Insight • Neutral

Monitor for any upcoming corporate events (earnings, pipeline updates) that could explain the timing, but this cluster alone does not signal insider concern. No trade action warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$89.55
T+0 close · Jul 8, 2026 · via day close
Latest settled
−29.13%
T+60 · $63.46
Vs SPY
−31.52%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 9 $89.55entry
  2. T+1 · 4mo ago −5.25%α −5.68% · $84.85
  3. T+5 · 4mo ago −12.32%α −12.19% · $78.52
  4. T+20 · 3mo ago −20.88%α −23.12% · $70.85
  5. T+60 · 7w ago −29.13%α −31.52% · $63.46
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two C-suite insiders (CTOO and EVP/CLO) sold a total of ~$2.6M in shares on July 6-7, 2026, predominantly tied to option exercises. The total value represents only ~0.036% of PTCT's $7.3B market cap, making this a routine liquidity-driven cluster. No bearish signal is warranted.

Key Financial Metrics

Direction
selling
Total Value
$2.6M
Insiders
2

Key Facts

  • Chief Technical Operations Officer Neil Gregory Almstead sold ~$2.19M in open-market shares (net of option exercises).
  • EVP and CLO Mark Elliott Boulding sold ~$406K in open-market shares (net of option exercises).
  • Total open-market sale value of ~$2.59M is only 0.036% of PTCT's market cap.
  • All sales coincide with option exercises, consistent with typical tax/vesting-related liquidity planning.

Financial Impact

~$2.59M in insider sales, immaterial relative to $7.3B market cap

dilution

Risk Factors

  • No material insider selling risk identified
  • Routine option-exercise-related sales do not imply negative outlook

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
81% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PTCT-1783576913200

Track record

29 reports on PTCT

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +19.01% at T+60 after the Apr 28, 2026 report. 5 of 6 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $62.09 Now $60.97 −1.80% settles Nov 17
  2. Nov 16, 2026today 144 Neutral 2/10 Entry $62.10 Now $60.97 −1.82% settles Nov 17
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $63.45 Now $60.97 −3.91% settles Nov 17
  4. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $64.14 to $64.91 Now $60.97 −4.94% ▲ +1.20% −0.12% vs SPY
  5. Nov 3, 202613d ago 8-K Neutral 3/10 Entry $68.12 to $68.97 Now $60.97 −10.50% ▲ +1.25% −0.40% vs SPY
  6. Nov 3, 202613d ago Press Release Neutral 3/10 Entry $68.12 to $68.97 Now $60.97 −10.50% ▲ +1.25% −0.40% vs SPY
  7. Nov 2, 202614d ago Institutional Cluster Bearish 4/10 Entry $68.12 to $68.97 Now $60.97 +10.50% ▼ −1.25% +0.40% vs SPY
  8. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $59.97 to $60.88 Now $60.97 +1.67% ▲ +1.52% +2.00% vs SPY
  9. Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $63.02 to $64.46 Now $60.97 −3.25% ▲ +2.29% +2.67% vs SPY
  10. Oct 16, 20264w ago Insider Cluster Neutral 3/10 Entry $61.53 to $62.92 Now $60.97 −0.91% ▲ +2.26% +1.92% vs SPY
Showing 10 of 29

US Market Status

Market Closed · Opens in 6h 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 9, 2026